Bioavailability Study of BIA 5-453

NCT03090568 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Congestive Heart Failure

Interventions

DRUG: BIA 5-453

Sponsor

Bial - Portela C S.A.